Your browser doesn't support javascript.
loading
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.
Lotan, Itay; Wilf-Yarkoni, Adi; Friedman, Yitzhak; Stiebel-Kalish, Hadas; Steiner, Israel; Hellmann, Mark A.
Affiliation
  • Lotan I; Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.
  • Wilf-Yarkoni A; Neuroimmunology Unit, Rabin Medical Center, Petah Tikva, Israel.
  • Friedman Y; Sackler Faculty of Medicine, Tel-Aviv University, Israel.
  • Stiebel-Kalish H; Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.
  • Steiner I; Neuroimmunology Unit, Rabin Medical Center, Petah Tikva, Israel.
  • Hellmann MA; Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Eur J Neurol ; 28(11): 3742-3748, 2021 11.
Article in En | MEDLINE | ID: mdl-34288285
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: